Andrew Reardon - Aug 10, 2025 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
CLO & Secretary
Signature
/s/ Andrew Reardon
Stock symbol
LGND
Transactions as of
Aug 10, 2025
Transactions value $
-$198,830
Form type
4
Date filed
8/12/2025, 04:34 PM
Previous filing
Jul 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reardon Andrew CLO & Secretary 555 HERITAGE DRIVE, SUITE 200, JUPITER /s/ Andrew Reardon 2025-08-12 0001950232

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$199K -1.33K -4.12% $150.06 30.8K Aug 10, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.